Pemetrexed (Alimta®, LY231514) demonstrates clinical activity in chemonaive patients with cervical cancer in a phase II single-agent trial
L. Goedhals, A. L. Van Wiyk, B. L. Smith, S. J. Fourie
International Journal of Gynecologic Cancer Apr 2006, 16 (3) 1172-1178; DOI: 10.1136/ijgc-00009577-200605000-00034